ppvipd: Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing...

Description Format Source References

Description

PPV23 (23-valent pneumococcal polysaccharide vaccine) with 3 Randomized Clinical Trials; 5 Cohort Studies and 3 Case-Control Studies.

The outcome variable IPD (Invasive Pneumococcal Disease).

Format

A matrix with 11 rows and 6 columns. Each row represents study results, the columns are:

name

Name of the first author and year.

TE

Treatment Effect as Log Odds Ratio.

seTE

Standard Error of the TE.

n.v

Number of patients in the vaccination group.

n.c

Number of patients in the control group.

design

Description of the study design.

Source

The data were obtainded from: Falkenhorst et al. (2017).

References

Falkenhorst, G., Remschmidt, C., Harder, T., Hummers-Pradier, E., Wichmann, O., and Bogdan, C. (2017) Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine(PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PLoS ONE 12(1): e0169368. doi:10.1371/journal.pone.0169368.

Verde, P.E. and Curcio, D. (2017) Hierarchical Meta-Regression Modelling: The Case of The Pneumococcal Polysaccharide Vaccine. Technical Report.


jarbes documentation built on March 11, 2019, 5:05 p.m.